A medical panel of US government advisers have recommended the Pfizer vaccine in children aged 5 to 11 years old.
This follows a conclusion from the panel that the benefits outweighed the known risks with the benefits being children’s health and ending school disruptions.
Following a day of presentations and debate, the final vote was 17 in favour and one abstention.
The Food and Drug Administration (FDA) is expected to give the go-ahead for vaccines in younger children, which makes 28 million of the American population.
One person who voted in favour of the proposal was Amanda Cohn of the Centres for Disease Control and Prevention (CDC), who stated, “It is pretty clear to me that the benefits do outweigh the risk when I hear about children who are being put in the ICU, who are having long-term outcomes after their Covid, and children are dying,”.
Cohn added that the risk of myocarditis would probably be very low as younger children would be receiving a lower dose of 10 micrograms rather than 30 micrograms used for adults.
However, the panel stated that it would not favour broad vaccine mandates in schools and should remain a personal decision for families.
Top FDA vaccine scientist Peter Marks stated that younger children were still at risk of being infected from Covid-19, adding that there have been 1.9 million infections and 8,300 hospitalisations.
He also stated that there have been 100 Covid-19 deaths reported in children which makes it the top 10 cause of death.
IMAGE – “Joe Biden” by Gage Skidmore is licensed under CC BY-SA 2.0/”201214-D-BN624-0811″ (CC BY 2.0) by U.S. Secretary of Defense